인쇄하기
취소
|
The NSAIDs (non-steroidal anti-inflammatory drugs) market, forming the annually KRW 400 billion market, is fluctuating. The industry is now paying attention to the fluctuation.
Changes have already been noticed in the COX-2 inhibitor market worth of KRW 60 billion annual sales while minor yet extraordinary movements have been started in the NSAIDs new drug field focusing on natural substances ...